New findings on brain functional connectivity may lend insights into mental disorders
August 31, 2017 – Ongoing advances in understanding the functional connections within the brain are producing exciting insights into how the brain circuits function together to support human behavior–and may lead to new discoveries in the development and treatment of psychiatric disorders, according to a review and update in the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Advanced neuroimaging techniques provide a new basis for studying circuit-level abnormalities in psychiatric disorders, according to the special perspectives article by Deanna M. Barch, PhD, of Washington University in St. Louis. She writes, “These advances have provided the basis for recent efforts to develop a more complex understanding of the function of brain circuits in health and of their relationship to behavior–providing, in turn, a foundation for our understanding of how disruptions in such circuits contribute to the development of psychiatric disorders.”
Functional Connectivity Data Point to New Understanding of Psychopathology
In recent years, large-scale research projects including the Human Connectome Project (HCP) have focused on defining and mapping the functional connections of the brain. The result is an extensive body of new evidence on functional connectivity and its relationship to human behavior.
In her article, Dr. Barch focuses on a technique called resting-state functional connectivity MRI (rsfcMRI), which measures how spontaneous fluctuations in blood oxygen level-dependent signals are coordinated across the brain. Analysis of rsfcMRI and other data in large numbers of subjects from the HCP will provide new insights into a wide range of psychiatric disorders, such as depression and anxiety, substance use, and cognitive impairment.
Recent studies have found that spontaneous activity from networks of regions across the brain are highly correlated even at rest (that is, when the person is not performing a specifically targeted task). This “resting state” activity may consume around 20 percent of the body’s total energy–even though the brain is only two percent of total body mass, according to Dr. Barch. “Ongoing resting-state activity may provide a critical and rich source of disease-relate variability.”
One key question is what constitutes the “regions” that make up the neural circuits of the brain. Recent rsfcMRI mapping studies have identified between 180 and 356 different brain regions, including many common regions that can be mapped across individuals. Future studies will look at whether these regions differ in shape, size, or location in people with psychiatric disorders–and whether these differences contribute to changes in the formation and function of brain circuits.
Some brain networks identified by rsfcMRI may play important roles in the functions and processes commonly impaired in psychiatric disorders. These include networks involved in cognitive (thinking) function, attention to internal emotional states, and the “salience” of events in the environment. Many questions remain as to how these brain networks are related to behavior in general, and to psychiatric disorders in particular.
Some researchers are using HCP data to study behavioral factors relevant to psychiatric issues, including cognitive function, mood, emotions, and substance use/abuse. Other studies are looking for rsfcMRI patterns related to individual differences in depression or anxiety, and their connections to various brain networks.
Dr. Barch’s research focuses on brain networks affecting the relationship between cognitive function and “psychotic-like” experiences. She notes that work on individual differences in functional connectivity in the HCP dataset is just getting started–the full HCP dataset was made publicly available in the spring of 2017.
“The hope is that these analyses will shed new light on how behavior of many different forms is related to functional brain connectivity, ultimately providing a new window for understanding psychopathology,” Dr. Barch writes. Continued studies of the relationships between brain circuitry and behavior might eventually lead to new therapeutic targets and new approaches to treatment monitoring and selection for patients with psychiatric disorders.
Click here to read “Resting-State Functional Connectivity in the Human Connectome Project: Current Status and Relevance to Understanding Psychopathology.”
Article: “Resting-State Functional Connectivity in the Human Connectome Project: Current Status and Relevance to Understanding Psychopathology.” (doi: 10.1097/HRP.0000000000000166)
About the Harvard Review of Psychiatry
The Harvard Review of Psychiatry is the authoritative source for scholarly reviews and perspectives on a diverse range of important topics in psychiatry. Founded by the Harvard Medical School Department of Psychiatry, the journal is peer reviewed and not industry sponsored. It is the property of Harvard University and is affiliated with all of the Departments of Psychiatry at the Harvard teaching hospitals. Articles encompass all major issues in contemporary psychiatry, including (but not limited to) neuroscience, psychopharmacology, psychotherapy, history of psychiatry, and ethics.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
For more information about Wolters Kluwer’s solutions and organization, visit http://www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.